Proteus syndrome is an ultra-rare disease with only 200 known cases worldwide. The journey to diagnosis for a 5-year-old girl named Valentina and her family was fraught with uncertainty and anxiety. Initially, a small bump on the head of the 8-month-old girl in 2020 raised suspicions, but a radiologist reassured the parents. The girl showed no alarming symptoms and lived a normal life, playing and eating happily. However, anomalies such as masses on the abdomen, patches under the chin, and heterochromia (one green eye and one brown eye) soon emerged.

Prescriptions for various analyses revealed that something was seriously wrong, but diagnosing the condition took months. In 2021, the diagnosis was finally confirmed: Valentina has Proteus syndrome, a disease characterized by progressive and uncontrolled growth of different parts of the body. It can affect bones, skin, adipose tissue, the central nervous system, blood vessels, and various internal organs. The condition affects fewer than one person per million, making it exceptionally rare.

Dr. Vincenzo Zuccotti, director of the Pediatric Department at the Buzzi Children’s Hospital in Milan, explained to the family, “A pathology characterized by progressive and uncontrolled growth of different parts of the body: it can affect bones, skin, adipose tissue, central nervous system, blood vessels and various internal organs. It affects less than one person on one million, about 200 cases diagnosed in the world.”

Valentina’s mother recounted to Corriere della Sera, “He had not yet turned two years old, the left ovary was removed (he had a benign adenoma) and in the spring of 2023 tonsils and wallpapers, also those who became too large.” Despite these challenges, Valentina remains a happy and intelligent child. The mother added, “She grows serene, she is a happy and intelligent child. For now the concerns are all of us parents. We live with a constant anxiety, thousands of doubts and very few certainties, because science on rare diseases proceeds slowly.”

The most difficult part of the journey has been acknowledging that there is no known cure for Proteus syndrome and that therapies are still in the experimental stages. Sabrina Buonamano, a specialist in rare diseases at the Bambino Gesù pediatric hospital in Rome, stated, “Thanks above all to the progress in genetics, we managed to put in point innovative treatments, which also make a ‘normal’ existence possible.” However, she emphasized, “But there are still too few rare diseases that have a cure.”

For Proteus syndrome, there is no cure, which is why encouraging scientific research is crucial. Buonamano supported this, saying, “That’s why it is necessary to encourage scientific research.”

Proteus syndrome is named after the Greek god Proteus, who could change his shape. The condition was first described in 1979, and since then, researchers have made significant strides in understanding its genetic basis. The syndrome is caused by a mutation in the AKT1 gene, which regulates cell growth. This discovery has paved the way for potential targeted therapies.

In the United States, organizations like the National Organization for Rare Disorders (NORD) and the Rare Disease Foundation play a pivotal role in supporting research and providing resources for families affected by rare diseases. These organizations often collaborate with academic institutions and pharmaceutical companies to accelerate the development of new treatments.

While there is currently no cure for Proteus syndrome, ongoing research offers hope. For instance, clinical trials are exploring the use of mTOR inhibitors, a class of drugs that can potentially slow down the abnormal cell growth associated with the syndrome. These trials are crucial in understanding the efficacy and safety of such treatments. Additionally, advancements in gene editing technologies like CRISPR-Cas9 hold promise for future therapies.

The journey of families like Valentina’s highlights the importance of early diagnosis and continuous support. Early intervention can significantly improve the quality of life for patients with Proteus syndrome. Support groups and community initiatives also provide invaluable emotional and practical support, helping families navigate the challenges of living with a rare disease.

Despite the challenges, Valentina’s story is a testament to resilience and the power of medical advancements. As research continues, there is hope that innovative treatments will be developed, offering a better future for children like Valentina. The quest for a cure for Proteus syndrome is ongoing, driven by the dedication of researchers, the support of families, and the courage of patients like Valentina.